CoQ10 200 mg

CoQ10 200 mg

Nutricost4.8 (1,275 ratings)
Format:Capsule Quantity: 60 Capsule(s) · 60 servings
Goals
$15.95 $0.26 per serving

Product analysis

54 out of 100

CoQ10 200 mg has a role in the body's energy processes and limited support for blood-vessel and blood-pressure measures in selected adults. Its exact preparation is not identified, making comparison with specific preparations harder.

AI assessment of the formula, label and price. How scoring works

Nutrient Quality20

The CoQ10 amount is stated, but its exact form and delivery are not identified. A particular advantage in absorption therefore cannot be established.

Ingredient Transparency63

The CoQ10 amount is clearly disclosed, helping you compare servings. The specific form is omitted, limiting comparisons between preparations.

Value For Money60

The serving cost provides reasonable value. Unclear form and delivery details limit how closely the price can be compared with specific preparations.

Customer Satisfaction85

Customer feedback is broadly positive across a large number of ratings. The volume provides a wider picture of satisfaction without proving health benefits.

Product Focus74

A single ingredient keeps the formula focused on CoQ10. Heart-related findings concern selected measures and populations, while everyday energy, metabolism and longevity benefits are less direct.

Format
Capsule
Container
60 Capsule(s)
Per serving
$0.26
Customer rating
4.8 · 1,275 ratings
Report analysis

Goals

Longevity
Impact
Moderate effect
A Ingredient FitD- PathwaysF EvidenceA+ Formulation Logic
Coenzyme Q-10 · 200 mg

CoQ10 supports mitochondrial energy production and antioxidant functions. The 200 mg serving meets the saved exposure comparison, but the supplied skin-aging evidence remains specific to an identified water-soluble preparation and does not show life extension.

How this product is rated for Longevity

Ingredient fit93

The counted ingredients are closely aligned with the aging-related functions assessed here. The counted amounts meet the saved exposure comparison.
Goal fit
The counted ingredients are closely aligned with the aging-related functions assessed here.
Dose adequacy
The counted amounts meet the saved exposure comparison.

Pathways40

The strongest supported mechanism is mitochondrial energy production, with moderate coverage. One mechanism reaches the saved coverage target; support across the other mechanisms remains limited.
Depth
The strongest supported mechanism is mitochondrial energy production, with moderate coverage.
Breadth
One mechanism reaches the saved coverage target; support across the other mechanisms remains limited.

Evidence30

Coenzyme Q-10 provides the strongest evidence contribution among ingredients counted at a sufficient amount, within the limited outcomes supplied. The counted preparation is not matched to the preparation used in the relevant supplied trials.
Evidence strength
Coenzyme Q-10 provides the strongest evidence contribution among ingredients counted at a sufficient amount, within the limited outcomes supplied.
Studied preparation
The counted preparation is not matched to the preparation used in the relevant supplied trials.

Formulation logic100

The counted ingredients can contribute independently or have their required partner. No configured ingredient conflict was identified in the supplied findings. 1 of 1 counted ingredients meet the saved minimum exposure threshold.
Partner coverage
The counted ingredients can contribute independently or have their required partner.
Conflicts
No configured ingredient conflict was identified in the supplied findings.
Effective doses
1 of 1 counted ingredients meet the saved minimum exposure threshold.
Study evidence
Heart Health
Impact
Highest effect
A Ingredient FitC PathwaysA+ EvidenceA+ Formulation Logic
Coenzyme Q-10 · 200 mg

Coenzyme Q10 has limited support for selected vascular, blood-pressure and lipid measures, with mixed results in dyslipidemic and treated hypertensive populations. The conventional declared active preparation is recognized separately from ubiquinol. Its serving amount receives full recognition, which does not establish a superior regimen, routine cardiovascular-event prevention or finished-product equivalence to a trial formulation.

How this product is rated for Heart Health

Ingredient fit93

The relevant ingredients are relatively focused on heart-health aspects. The counted amounts receive full recognition; this does not establish additional cardiovascular benefit from increasing them.
Goal fit
The relevant ingredients are relatively focused on heart-health aspects.
Dose adequacy
The counted amounts receive full recognition; this does not establish additional cardiovascular benefit from increasing them.

Pathways60

The relevant ingredient contribution is assigned to endothelial vascular function; this does not establish clinical-event prevention. Only one evaluated pathway meets the breadth threshold.
Depth
The relevant ingredient contribution is assigned to endothelial vascular function; this does not establish clinical-event prevention.
Breadth
Only one evaluated pathway meets the breadth threshold.

Evidence98

Coenzyme Q-10 leads the saved finding. The counted preparations receive recognition, without proving the same population, duration or clinical outcome.
Evidence strength
Coenzyme Q-10 leads the saved evidence finding; clinical interpretation remains specific to the ingredient and outcome.
Studied preparation
The counted preparations receive recognition, without proving the same population, duration or clinical outcome.

Formulation logic100

Each counted ingredient works independently or has its required partner; no extra combined benefit is established. No configured conflict was matched.
Partner coverage
Each counted ingredient works independently or has its required partner; no extra combined benefit is established.
Conflicts
No configured ingredient conflict was matched.
Effective doses
All counted ingredients meet the amount inclusion criterion, which is distinct from a clinically proven prevention threshold.
Study evidence
Energy
Impact
Moderate effect
A Ingredient FitF PathwaysF EvidenceA+ Formulation Logic
Coenzyme Q-10 · 200 mg

CoQ10 participates in mitochondrial energy production and has limited, preparation-specific fatigue evidence. The 200 mg declaration lacks an identified ubiquinol or ubiquinone form, so its contribution is less direct than for the preparations described in the supplied evidence.

How this product is rated for Energy

Ingredient fit93

The saved assessment identifies 1 relevant ingredients and no other active ingredients; the formula serves 6 goals. The saved amount assessment is strong overall, with unknown amounts contributing no support.
Goal fit
The saved assessment identifies 1 relevant ingredients and no other active ingredients; the formula serves 6 goals.
Dose adequacy
The saved amount assessment is strong overall, with unknown amounts contributing no support.

Pathways17

Mitochondrial energy production is the strongest represented mechanism, with partial coverage in the saved findings. 0 of the three mechanism targets meets the saved coverage threshold.
Depth
Mitochondrial energy production is the strongest represented mechanism, with partial coverage in the saved findings.
Breadth
0 of the three mechanism targets meets the saved coverage threshold.

Evidence27

Coenzyme Q-10 leads the saved evidence comparison among ingredients meeting the amount threshold. This comparison does not imply uniform fatigue relief. The saved evidence match is incomplete for Coenzyme Q-10.
Evidence strength
Coenzyme Q-10 leads the saved evidence comparison among ingredients meeting the amount threshold. This comparison does not imply uniform fatigue relief.
Studied preparation
The saved evidence match is incomplete for Coenzyme Q-10.

Formulation logic100

The assessed ingredients work alone or have their required partner. No configured conflict was identified. 1 of 1 assessed ingredients meet the saved minimum amount threshold.
Partner coverage
The assessed ingredients work alone or have their required partner.
Conflicts
No configured conflict was identified.
Effective doses
1 of 1 assessed ingredients meet the saved minimum amount threshold.
Study evidence
Cardiovascular Support
Impact
Highest effect
A Ingredient FitC PathwaysA- EvidenceA+ Formulation Logic
Coenzyme Q-10 · 200 mg

CoQ10 has limited support for improvements in blood pressure, lipids or blood-vessel markers in selected adults with abnormal lipids. The declared 200 mg per serving meets the saved amount reference, but exceeding the cited 120 mg daily study amount does not establish proportionately greater benefit. The generic CoQ10 declaration does not identify a superior delivery or redox form. These marker findings do not establish prevention of cardiovascular events or relief of statin-related symptoms.

How this product is rated for Cardiovascular Support

Ingredient fit93

CoQ10 is the only included ingredient and meets its saved amount reference. Several linked goals make the product's focus broader than cardiovascular support alone.
Goal fit
The included ingredient supports the goal, while several linked goals reduce the exclusive cardiovascular focus.
Dose adequacy
The 200 mg CoQ10 serving meets the saved reference; larger amounts do not establish proportionately greater benefit.

Pathways60

The saved findings concentrate on blood-vessel lining function through CoQ10, without broad coverage across cardiovascular processes.
Depth
Blood-vessel lining function reaches full coverage in the saved findings.
Breadth
Blood-vessel lining function is the only process reaching the saved coverage threshold.

Evidence88

Declared CoQ10 is counted as a studied preparation, with evidence confined to selected cardiovascular markers and populations.
Evidence strength
CoQ10 supplies the strongest included evidence, below the framework's highest cardiovascular evidence category.
Studied preparation
The declared CoQ10 active is counted as studied, without establishing superiority of an unspecified form.

Formulation logic100

CoQ10 clears the saved minimum and requires no partner. No listed conflict was detected.
Partner coverage
CoQ10 can contribute without a required partner ingredient.
Conflicts
No conflict covered by the supplied checks was detected.
Effective doses
CoQ10 clears the saved minimum for inclusion, without predicting an individual cardiovascular benefit.
Study evidence
Metabolism Support
Impact
High effect
A Ingredient FitD+ PathwaysB- EvidenceA+ Formulation Logic
Coenzyme Q-10 · 200 mg

Coenzyme Q10 helps mitochondria transfer energy as part of normal cell function. That role does not establish that this serving raises whole-body energy expenditure. The supplied metabolic-control findings concern a different outcome, and neither a durable fat-loss effect nor an advantage of a particular CoQ10 form is established.

How this product is rated for Metabolism Support

Ingredient fit93

Coenzyme Q-10 supplies the product's counted contribution, with full amount allowance in the saved comparison.
Goal fit
Coenzyme Q-10 is the sole credited ingredient; the product is also linked to other goals.
Dose adequacy
The declared serving reaches the comparison's full amount allowance; that does not establish a greater biological benefit.

Pathways54

The saved findings mainly concern mitochondrial energy and fat oxidation, with limited breadth across other routes.
Depth
The strongest represented route is mitochondrial energy and fat oxidation; this describes the saved ingredient mapping, not a measured rise in energy expenditure.
Breadth
Only one route reaches the comparison's coverage threshold, so the findings do not span several mechanisms.

Evidence75

The retained findings must be interpreted alongside the distinction between ordinary metabolic roles and a demonstrated increase in energy expenditure.
Evidence strength
CoQ10's mitochondrial role does not establish increased whole-body energy expenditure.
Studied preparation
The saved findings accept the counted preparations; this does not establish that this exact product or combination increased energy expenditure.

Formulation logic100

The retained ingredients meet the amount check and have no missing required partners. No evaluated ingredient conflict was triggered.
Partner coverage
No required partner is missing among the counted ingredients; this does not establish extra benefit from combining them.
Conflicts
None of the evaluated ingredient conflicts was triggered.
Effective doses
All ingredients retained for this check meet its amount threshold; the threshold is not a proven clinical minimum.
Study evidence
Inflammation
Impact
High effect
B Ingredient FitD PathwaysA EvidenceA+ Formulation Logic
Coenzyme Q-10 · 200 mg

Coenzyme Q-10 supports mitochondrial and antioxidant processes. Its anti-inflammatory relevance comes from a small ubiquinone trial in statin-treated coronary disease, where one inflammatory marker improved but CRP and IL-6 did not. The 200 mg serving is below the trial's 300 mg daily exposure, so the amount does not establish the same response.

How this product is rated for Inflammation

Ingredient fit80

Coenzyme Q-10 is the sole credited ingredient, though linked to several goals.
Goal fit
Coenzyme Q-10 is the sole credited ingredient, though linked to several goals.
Dose adequacy
The 200 mg serving receives partial amount-based recognition and remains below the supplied 300 mg daily study exposure.

Pathways46

Oxidative and mitochondrial stress is the main area represented. Coverage of other areas is limited.
Depth
Oxidative and mitochondrial stress is the strongest area in the saved findings; this mapping does not establish a clinical effect.
Breadth
Only oxidative and mitochondrial stress reaches the saved coverage threshold, so coverage is narrow.

Evidence93

Coenzyme Q-10 leads the saved evidence finding. The preparation is recognized, while the clinical limitations described above still apply.
Evidence strength
Coenzyme Q-10 leads the saved evidence finding; this does not establish routine clinical anti-inflammatory benefit.
Studied preparation
The saved findings recognize the preparations of all credited ingredients; this does not establish equivalence for every clinical outcome.

Formulation logic100

The credited ingredients have no unmet partner requirement or matched conflict in the saved findings. Their amounts clear the threshold used for inclusion.
Partner coverage
Each credited ingredient can contribute independently or has its required partner.
Conflicts
No configured conflict was matched; this is limited to the combinations evaluated.
Effective doses
All credited ingredients clear the amount threshold used for inclusion; this is not proof of an effective clinical dose.
Study evidence

Ingredients

IngredientAmount per servingScore
Coenzyme Q-10
200 mg 46
Gluten Free Adults 18–50
Report overview
Coenzyme Q-10 · 200 mg OverallScore46
F Active Ingredient Quality & BioavailabilityB- Dose, Safety & Label TransparencyC Value
A serving provides 200 mg of CoQ10. The saved facts do not identify its molecular form, limiting a form-specific absorption comparison.
How this ingredient is rated

Active Ingredient Quality & Bioavailability12

The CoQ10 form is not identified in the saved facts. No configured absorption enhancer is recorded.
Molecular Form: Ubiquinol vs. Ubiquinone
The saved facts do not identify whether the CoQ10 is ubiquinol or ubiquinone, so form-specific absorption cannot be assessed.
Formulation & Absorption Enhancers
The saved evaluation records no configured special delivery technology or black pepper extract as an absorption enhancer.

Dose, Safety & Label Transparency72

The CoQ10 amount is stated as 200 mg per serving.
Clinical Dosage Alignment
The recorded amount is 200 mg of CoQ10 per serving.
Label Transparency & Fillers
The CoQ10 amount is stated, and the checked other ingredients contain no additives or fillers flagged by the evaluation.

Value60

The whole-product serving costs about $0.27, the evaluated price.
Price Per Effective Serving
The whole-product serving costs about $0.27, the evaluated price.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Effects of Coenzyme Q10 Supplementation on Lipid Profiles in Adults: A Meta-analysis of Randomized Controlled Trials.
    Liu Z; Tian Z; Zhao D; Liang Y; Dai S; Liu M; Hou S; Dong X; Zhaxinima; Yang Y · The Journal of clinical endocrinology and metabolism · 2022
    Meta-analysis2,794 participants50 studies pooledCardiovascular Support Heart Health forCoenzyme Q-10
  2. Six-month supplementation with high dose coenzyme Q10 improves liver steatosis, endothelial, vascular and myocardial function in patients with metabolic-dysfunction associated steatotic liver disease: a randomized double-blind, placebo-controlled trial.
    Vrentzos E; Ikonomidis I; Pavlidis G; Katogiannis K; Korakas E; Kountouri A; Pliouta L; Michalopoulou E; Pelekanou E; Boumpas D; Lambadiari V · Cardiovascular diabetology · 2024
    Randomized trial60 participantsCardiovascular Support forCoenzyme Q-10
  3. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial.
    Mortensen SA; Rosenfeldt F; Kumar A; Dolliner P; Filipiak KJ; Pella D; Alehagen U; Steurer G; Littarru GP; Q-SYMBIO Study Investigators · JACC. Heart failure · 2015
    Randomized trial420 participantsCardiovascular Support forCoenzyme Q-10
  4. [Coenzyme Q-10 in the treatment of patients with chronic heart failure and reduced left ventricular ejection fraction: systematic review and meta-analysis].
    Mareev VY; Mareev YV; Begrambekova YL · Kardiologiia · 2022
    Meta-analysis1,139 participants6 studies pooledCardiovascular Support forCoenzyme Q-10
  5. Effect of coenzyme Q10 in Europeans with chronic heart failure: A sub-group analysis of the Q-SYMBIO randomized double-blind trial.
    Mortensen AL; Rosenfeldt F; Filipiak KJ · Cardiology journal · 2020
    Randomized trialCardiovascular Support forCoenzyme Q-10
  6. Effects of Coenzyme Q10 on Statin-Induced Myopathy: An Updated Meta-Analysis of Randomized Controlled Trials.
    Qu H; Guo M; Chai H; Wang WT; Gao ZY; Shi DZ · Journal of the American Heart Association · 2019
    Meta-analysis575 participants12 studies pooledEnergy forCoenzyme Q-10
  7. Coenzyme Q10 Supplementation in Athletes: A Systematic Review.
    Fernandes MSS; Fidelis DEDS; Aidar FJ; Badicu G; Greco G; Cataldi S; Santos GCJ; de Souza RF; Ardigò LP · Nutrients · 2026
    Systematic review16 studies pooledEnergy forCoenzyme Q-10
  8. Effectiveness of Coenzyme Q10 Supplementation for Reducing Fatigue: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Tsai IC; Hsu CW; Chang CH; Tseng PT; Chang KV · Frontiers in pharmacology · 2024
    Meta-analysis1,126 participants13 studies pooledEnergy forCoenzyme Q-10
  9. Antifatigue effects of coenzyme Q10 during physical fatigue.
    Mizuno K; Tanaka M; Nozaki S; Mizuma H; Ataka S; Tahara T; Sugino T; Shirai T; Kajimoto Y; Kuratsune H; Kajimoto O; Watanabe Y · Nutrition (Burbank, Los Angeles County, Calif.) · 2008
    Randomized trial17 participantsEnergy forCoenzyme Q-10
  10. Effect of coenzyme Q10 supplementation on fatigue: A systematic review of interventional studies.
    Mehrabani S; Askari G; Miraghajani M; Tavakoly R; Arab A · Complementary therapies in medicine · 2019
    Systematic review16 studies pooledEnergy forCoenzyme Q-10
  11. Ubiquinol Ameliorates Endothelial Dysfunction in Subjects with Mild-to-Moderate Dyslipidemia: A Randomized Clinical Trial.
    Sabbatinelli J; Orlando P; Galeazzi R; Silvestri S; Cirilli I; Marcheggiani F; Dludla PV; Giuliani A; Bonfigli AR; Mazzanti L; Olivieri F; Antonicelli R; Tiano L · Nutrients · 2021
    Randomized trial51 participantsHeart Health forCoenzyme Q-10
  12. Dose-Response Effect of Coenzyme Q10 Supplementation on Blood Pressure among Patients with Cardiometabolic Disorders: A Grading of Recommendations Assessment, Development, and Evaluation (GRADE)-Assessed Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Zhao D; Liang Y; Dai S; Hou S; Liu Z; Liu M; Dong X; Zhan Y; Tian Z; Yang Y · Advances in nutrition (Bethesda, Md.) · 2022
    Meta-analysis1,831 participants26 studies pooledHeart Health forCoenzyme Q-10
  13. Effects of Coenzyme Q10 on Lipid, Glycemic, and Inflammatory Markers in Metabolic Disorders: A Systematic Review and Meta-Analysis.
    Zhang Z; Liu Z; Geng Y; Huang Y; Hu R; Li F; Song Y; Zhang M · Journal of diabetes research · 2026
    Meta-analysis3,422 participants64 studies pooledHeart Health Metabolism Support forCoenzyme Q-10
  14. Treatment of coenzyme Q10 for 24 weeks improves lipid and glycemic profile in dyslipidemic individuals.
    Zhang P; Yang C; Guo H; Wang J; Lin S; Li H; Yang Y; Ling W · Journal of clinical lipidology · 2019
    Randomized trial101 participantsHeart Health forCoenzyme Q-10
  15. The effect of coenzyme Q10 supplementation on inflammatory and endothelial dysfunction markers in overweight/obese polycystic ovary syndrome patients.
    Taghizadeh S; Izadi A; Shirazi S; Parizad M; Pourghassem Gargari B · Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology · 2021
    Randomized trial43 participantsInflammation forCoenzyme Q-10
  16. The effects of coenzyme Q10 supplementation on metabolic profiles and parameters of mental health in women with polycystic ovary syndrome.
    Karamali M; Gholizadeh M · Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology · 2022
    Randomized trial55 participantsInflammation forCoenzyme Q-10
  17. Efficacy and Optimal Dose of Coenzyme Q10 Supplementation on Inflammation-Related Biomarkers: A GRADE-Assessed Systematic Review and Updated Meta-Analysis of Randomized Controlled Trials.
    Hou S; Tian Z; Zhao D; Liang Y; Dai S; Ji Q; Fan Z; Liu Z; Liu M; Yang Y · Molecular nutrition & food research · 2023
    Meta-analysis1,517 participants31 studies pooledInflammation forCoenzyme Q-10
  18. Can coenzyme Q10 supplementation effectively reduce human tumor necrosis factor-α and interleukin-6 levels in chronic inflammatory diseases? A systematic review and meta-analysis of randomized controlled trials.
    Farsi F; Heshmati J; Keshtkar A; Irandoost P; Alamdari NM; Akbari A; Janani L; Morshedzadeh N; Vafa M · Pharmacological research · 2020
    Meta-analysis509 participants9 studies pooledInflammation forCoenzyme Q-10
  19. Promising efficacy of coenzyme Q10 supplementation as adjunctive therapy in juvenile idiopathic arthritis: a randomized-controlled pilot study.
    Elsherif N; Shousha G; Sabri NA; Shawki MA · Immunopharmacology and immunotoxicology · 2026
    Randomized trial58 participantsInflammation forCoenzyme Q-10
  20. Coenzyme Q10 and Degenerative Disorders Affecting Longevity: An Overview.
    Mantle D; Hargreaves I · Antioxidants (Basel, Switzerland) · 2020
    Narrative reviewLongevity forCoenzyme Q-10